Catalent will recognize 80 years of softgel advancements with presentations at INTERPHEX.
Catalent will recognize 80 years of softgel advancements at INTERPHEX on March 18-20, 2014 in New York City with presentations from its senior management team, as well as graduates from the company’s Global Operations Leadership Development (GOLD) program.
On Wednesday, March 19, Sridhar Krishnan, Catalent’s vice president, Global Operations, will present “Catalent GOLD - Accelerating Leadership Pipeline in Pharma & Biotech.” Catalent’s GOLD program is a two-year leadership development opportunity, designed for university graduates who have a desire to accelerate their career growth in an entrepreneurial, fast-paced environment. Krishnan’s presentation, which takes place from 10:30 to 11:30 AM, will outline the GOLD leadership model and feature the experiences of three graduates who have participated in the program.
Also on Wednesday 19, from 2:45 to 3:45 PM, Akan Oton, director, Global Licensing & CorporateAlliances, will lead a discussion on “Commercializing Emerging Drug Delivery Technologies.” His presentation will address the evolving role of drug delivery in pharma products from a commercial perspective and will look at current trends in drug delivery and unmet needs currently being pursued. He will also give examples of a typical path to commercialization of drug delivery technologies by innovators.
On Thursday, March 20, from 11:45 AM to 12:45 PM, Bill Hartzel, director, Strategic Execution, Advanced Delivery Technologies will present, “Advanced Aseptic Processing to Reduce Risk with Sterile Fill/Finish.” His presentation will feature ways to identify the QbD elements of Blow/Fill/Seal equipment and the evaluation of the risk mitigation properties of advanced aseptic properties as well astaking a look at Catalent’s newly launched ADVASEPT technology.
Source: Catalent
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.